The transforming role of wharton’s jelly mesenchymal stem cell-derived exosomes for diabetic foot ulcer healing: a randomized controlled clinical trial
Our research proved that MSC-Exos is a viable treatment option for DFUs. MSC-Exos provide a multimodal approach to improve wound healing outcomes in diabetes patients.
Authors
- Zakia Hamed
- Mohamed M. Bahr (ORCID: https://orcid.org/0000-0001-9340-9064)
- Mohamed S. Kishta (ORCID: https://orcid.org/0000-0002-2314-8820)
- Tamer Hydara
- Ahmed N. Abdallah (ORCID: https://orcid.org/0000-0003-0517-6470)
- Ashraf Shamaa
- Abdel -Hafez
Institutions
- Kafrelsheikh University (EG)
- Cairo University (EG)
- National Research Centre (EG)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1186/s13287-025-04690-y
- Citations
- 8
- Primary Topic
- Diabetic Foot Ulcer Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.36
Funders
- Kafrelsheikh University
- Science and Technology Development Fund